RPC
BMY icon

Rossmore Private Capital’s Bristol-Myers Squibb BMY Stock Holding History

Rossmore Private Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,906
Closed -$534K – 345
2025
Q4 		$534K Sell
9,906
-6,715
-40% -$323K 0.05% 195
2025
Q3 		$750K Sell
16,621
-3,316
-17% -$155K 0.08% 158
2025
Q2 		$923K Sell
19,937
-364
-2% -$17.9K 0.11% 137
2025
Q1 		$1.24M Buy
20,301
+347
+2% +$20.2K 0.15% 116
2024
Q4 		$1.13M Hold
19,954
– – 0.14% 112
2024
Q3 		$1.03M Sell
19,954
-3,547
-15% -$166K 0.13% 126
2024
Q2 		$976K Sell
23,501
-13,542
-37% -$606K 0.13% 123
2024
Q1 		$2.01M Sell
37,043
-23,301
-39% -$1.19M 0.26% 78
2023
Q4 		$3.1M Sell
60,344
-8,846
-13% -$464K 0.44% 56
2023
Q3 		$4.02M Sell
69,190
-55
-0.1% -$3.37K 0.61% 42
2023
Q2 		$4.43M Sell
69,245
-2,001
-3% -$134K 0.66% 42
2023
Q1 		$4.94M Buy
71,246
+472
+0.7% +$33.3K 0.77% 39
2022
Q4 		$5.09M Buy
70,774
+1
+0% +$75 0.82% 36
2022
Q3 		$5.03M Buy
70,773
+238
+0.3% +$17.3K 0.9% 31
2022
Q2 		$5.43M Sell
70,535
-2,069
-3% -$158K 0.94% 30
2022
Q1 		$5.3M Sell
72,604
-355
-0.5% -$23.8K 0.83% 30
2021
Q4 		$4.55M Sell
72,959
-17,014
-19% -$998K 0.71% 38
2021
Q3 		$5.32M Buy
89,973
+21
+0% +$1.38K 0.91% 29
2021
Q2 		$6.01M Sell
89,952
-255
-0.3% -$16.6K 1.03% 25
2021
Q1 		$5.7M Buy
90,207
+2,353
+3% +$146K 1.07% 24
2020
Q4 		$5.45M Buy
87,854
+6,848
+8% +$421K 1.1% 23
2020
Q3 		$4.88M Buy
81,006
+9,865
+14% +$594K 1.15% 22
2020
Q2 		$4.18M Buy
71,141
+5,139
+8% +$307K 1.16% 20
2020
Q1 		$3.69M Buy
66,002
+16,822
+34% +$1.03M 1.28% 17
2019
Q4 		$3.16M Buy
49,180
+30,615
+165% +$1.75M 0.97% 27
2019
Q3 		$941K Buy
+18,565
New +$873K 0.32% 61
2018
Q1 		– Sell
-148
Closed -$9.07K – 139
2017
Q4 		$9.07K Buy
+148
New +$9.26K 0.01% 311

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rossmore Private Capital's BMY Position: Q1 2026 in Review

Rossmore Private Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 9,906 shares — an estimated $534K sold.

Rossmore Private Capital first reported a position in BMY in Q4 2017 and held it in 27 quarters. The position peaked at $6.01M in Q2 2021. 2,534 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Rossmore Private Capital reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Rossmore Private Capital sold 9,906 Bristol-Myers Squibb shares in Q1 2026, an estimated $534K.
  • Rossmore Private Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 27 quarters.
  • Rossmore Private Capital's Bristol-Myers Squibb position peaked at $6.01M in Q2 2021.
  • 2,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Rossmore Private Capital's 13F filing for Q1 2026, filed 1 May 2026.